ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | 50,170 | $1,027,985 | 0.00% |
| Amundi | 4,652 | $81,643 | 0.00% |
| DEUTSCHE BANK AG\ | 36,196 | $741,656 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 2,343 | $48,008 | 0.00% |
| Invesco Ltd. | 53,928 | $1,104,984 | 0.00% |
| NATIXIS | 649 | $13,298 | 0.00% |
| Gradient Investments LLC | 34 | $697 | 0.00% |
| ROYAL BANK OF CANADA | 10,813 | $222,000 | 0.00% |
| WOLVERINE TRADING, LLC | 19,000 | $389,310 | 0.00% |
| BANK OF MONTREAL /CAN/ | 35,000 | $824,950 | 0.00% |
External links
This page lists ROCKET PHARMACEUTICALS INC's shareholders in Q3 2023. To view ROCKET PHARMACEUTICALS INC's shareholder history, click here.